Biometrics74, 1014–1022DOI: 10.1111/biom.12838
September 2018
Regression Analysis for Secondary Response Variable
in a Case-Cohort Study
Yinghao Pan
,
1
Jianwen Cai,
1
Sangmi Kim,
2
and Haibo Zhou
1,
*
1
Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill,
North Carolina 27599, U.S.A.
2
Medical College of Georgia, GRU Cancer Center, Augusta University, Augusta, Georgia 30912, U.S.A.
∗
email:[email protected]
Summary. Case-cohort study design has been widely used for its cost-effectiveness. In any real study, there are always other
important outcomes of interest beside the failure time that the original case-cohort study is based on. How to utilize the
available case-cohort data to study the relationship of a secondary outcome with the primary exposure obtained through the
case-cohort study is not well studied. In this article, we propose a non-parametric estimated likelihood approach for analyzing
a secondary outcome in a case-cohort study. The estimation is based on maximizing a semiparametric likelihood function
that is built jointly on both time-to-failure outcome and the secondary outcome. The proposed estimator is shown to be
consistent, efficient, and asymptotically normal. Finite sample performance is evaluated via simulation studies. Data from the
Sister Study is analyzed to illustrate our method.
Key words:Case-cohort design; Estimated likelihood; Secondary outcome; Semiparametric; Validation sample.
1. Introduction
The case-cohort study design (Prentice, 1986) is a cost-
effective sampling strategy that is used to study the
association between an often expensive exposure variable and
a time-to-event outcome. One example of a case-cohort study
is the Sister Study conducted by NIEHS (Kim et al., 2011,
2013), where the time-to-event outcome of interest is time to
breast cancer and the expensive exposure measure is a major
prostaglandin E2 metabolite (PGE-M). The Sister Study tar-
gets U.S. women who have a sister with breast cancer, but
with no breast cancer themselves at the enrollment. The case-
cohort study design can be viewed as a two-phased study. In
the first phase, information on the time-to-event outcome and
some relatively easy-to-obtain covariates are measured on all
cohort members. In the second phase, the exposure variable
of interest is measured in a random sample of the full cohort,
plus those subjects who experienced the event of interest. The
simple random sample here is referred as subcohort and those
failures are referred as the cases. Many methods have been
proposed to estimate the hazard ratio parameters with case-
cohort data, for example, Prentice (1986), Self and Prentice
(1988), Chen and Lo (1999), Borgan et al. (2000), Kulich and
Lin (2004), Kang and Cai (2009), Kim et al. (2013). For binary
response outcome-dependent-sampling data, related work was
done by Wang and Zhou (2006, 2010).
With tremendous cost and efforts involved in collecting
the exposure variable in case-cohort study, interest rises to
use the collected case-cohort data to study the relationship
between other important responses to the exposure. Relative
to the failure time used to design the case-cohort study, these
important responses are referred as the secondary responses.
For instance, in our Sister Study, investigators are interested
in studying the relationship between BMI and PGE-M since
recent research has indicated that there might be a positive
association between obesity and prostaglandin E2 (Morris
et al., 2011; Subbaramaiah et al., 2011). How to analyze the
secondary outcome (BMI in this case) in a case-cohort study
efficiently and correctly is not a straightforward exercise, as
the original study data are obtained in an outcome-dependent
way (depend on the primary outcome, i.e., the time-to-event
variable). This is an issue that puzzled investigators who try
to take advantage of the exposure variable measured in the
original case-cohort study, yet not sure how to handle the
biased sampling nature of the data based on the primary time-
to-event outcome. Naively treating the case-cohort sample as
a simple random sample could cause biased inference, as later
shown in our simulation studies. An inefficient approach is to
take the subcohort portion of the biased sampling data, and
ignore those of cases. Clearly, this approach is discarding a big
portion of the data. A significant amount of work was done on
secondary analysis of case-control or nested case-control data.
This includes the likelihood-based approach (Lee et al., 1997;
Jiang et al., 2006; Saarela et al., 2008; Lin and Zeng, 2009;
Salim et al., 2014); inverse probability weighting (Richardson
et al., 2007; Monsees et al., 2009); and estimating equation
(Wei et al., 2013; Ma and Carroll, 2016). Saarela et al. (2012)
proposed a conditional likelihood method for secondary anal-
ysis under general two-phase cohort sampling designs, which
includes case-cohort design. However, there has been a lack of
research on the secondary response regression analysis in the
case-cohort study in general.
Our research is motivated by the need in the Sister Study,
where we aim to establish the relationship between PGE-M
and BMI. In this article, we propose an estimated likelihood
1014©
2017, The International Biometric Society
Regression Analysis for Secondary Response Variable in a Case-Cohort Study1015
method for linear regression analysis of a continuous sec-
ondary response variable using case-cohort data. We jointly
model the time-to-event outcome (time to breast cancer)
and the continuous secondary response (BMI). The likeli-
hood function involves the conditional distribution of the
expensive exposure given other inexpensive covariates. We
estimate it in a non-parametric fashion. We compare our
proposed estimated likelihood estimator to two inverse prob-
ability weighting (IPW) type estimators we developed, and
show that the estimated likelihood method has greater sta-
tistical efficiency. The advantage of our proposed method
is that it is efficient, and yet require no strong parametric
assumptions. The performance of our estimator is explored
under a variety of conditions where complications could
arrive.
The organization of the article is as follows. In Section 2, we
present some notations, data structure, and model for case-
cohort design. In Section 3, we outline the estimation algo-
rithm for our proposed estimated likelihood estimator and
establish its asymptotic properties. We further develop two
new IPW type estimators in Section 4. In Section 5, we
investigate the finite sample performance of our proposed esti-
mators via simulation studies. In Section 6, we apply our
method to Sister Study data. Final remarks are given in
Section 7.
2. Data Structure and Model
We consider efficient inference of a continuous secondary
response, denoted byY
2
, with respect to an expensive expo-
sure, denoted byX, in a case-cohort design. To fix notation,
let
̃
Tdenote the primary event time of interest andCthe cen-
soring time. LetT=min(
̃
T,C), and=I(
̃
T≤C), whereTis
the observation time, andis the event indicator. Through-
out the article, we refer to individuals who have the event as
cases (=1) and censored individuals as non-cases (=0).
Furthermore, let (X,Z) denote the vector of covariates with
Xbeing the expensive scalar covariate obtained only for the
subcohort and the cases, andZbeing the other first-phase
covariates.Zcan be either discrete or continuous variables.
We assume that
̃
TandCare conditionally independent given
(Y
2
,X,Z), and the censoring timeCdoes not depend onX
but can depend onY
2
andZ.
We assume that the underlying data{(T
i
,
i
,Y
2i
,X
i
,Z
i
),i=
1,...,N}are independent and identically distributed random
vectors, whereNdenotes the size of the full cohort. Case-
cohort studies can be considered as two-phase studies: in the
first phase, information on observation time, event indicator,
secondary response, and inexpensive covariates are gathered
for each member of the full cohort. That is, we observe
{(T
i
,
i
,Y
2i
,Z
i
),i=1,...,N}. In the second phase, covariate
Xis measured for subjects in the subcohort, and those who
experienced the event of interest (
i
=1). LetV
0
be the index
set of the simple random sample taken from the baseline
cohort, andV
1
be the index set of the remaining cases in
the full cohort. Then we observe{X
i
,i∈V
0
∪V
1
}in the sec-
ond phase. Letn
SRS
be the size of the subcohort,n
V
1
be the
size of the supplemental cases. Here,n
SRS
is a pre-specified
number andn
V
1
is a random variable.
Letn
V
=n
SRS
+n
V
1
be the number of individuals for which
we observedX, and letn
̄
V
=N−n
V
be the number of
individuals for whomXis not observed. Borrowing the ter-
minology from measurement error literature, we will refer
to then
V
complete observations as the validation sample,
andn
̄
V
incomplete observations as non-validation sample. Let
V=V
0
∪V
1
be the index set of the validation sample, and
̄
Vbe the index set of the non-validation sample. In addi-
tion, letR
i
indicates whether theith subject is selected into
the validation sample, thenV={i:R
i
=1}and
̄
V={i:R
i
=
0}. The data structure for the problem we consider is the
following:
First phase:{T
i
,
i
,Y
2i
,Z
i
},i=1,...,N;
Second phase:{subcohort sample}{X
i
},i∈V
0
;
{supplemental cases}{X
i
|
i
=1,i /∈V
0
},i∈V
1
.
(1)
The main interest in this article is to model the association
betweenXand the secondary responseY
2
, adjusting forZin
the population from the following linear model:
Y
2
=β
0
+β
1
X+β
2
Z+,(2)
where∼N(0,σ
2
), and’s are independent. We note that
model (2) above, not model (3) below, is the main model
for this article. Our goal is to develop an efficient inference
procedure onβ=(β
0
,β
1
,β
2
).
Without loss of generality, we assume the following Cox
model (Cox, 1972) for the primary response variable:
λ(t|X, Y
2
,Z)=λ
0
(t) exp(γ
1
X+γ
2
Y
2
+γ
3
Z),(3)
whereλ(t|X, Y
2
,Z) is the conditional hazard function of
̃
T
given (X, Y
2
,Z), andλ
0
(t) is the baseline hazard function.
Let
0
(t)=
∫
t
0
λ
0
(u)dudenote the baseline cumulative hazard
function.
3. Estimated Likelihood Approach
Letf(·|·) denote the conditional density function, and
G(·|·) denote the conditional distribution function. LetW
be the informative components ofZaboutX, in the sense
thatG
X|Z
(x|z)=G
X|W
(x|w). If we are to jointly model
(T, , Y
2
), then the full-information likelihood for data in (1)
is proportional to
L
N
(ξ,
0
(t))=
∏
i∈V
f(T
i
,
i
,Y
2i
|X
i
,Z
i
)
×
∏
j∈
̄
V
{
∫
x
f(T
j
,
j
,Y
2j
|x,Z
j
)dG
X|W
(x|W
j
)
}
,
(4)
1016Biometrics, September2018
whereξ=(β,γ,σ
2
). The log-likelihood of (4) takes the form:
l
N
(ξ,
0
(t))=
∑
i∈V
{
logf
γ
(T
i
,
i
|X
i
,Y
2i
,Z
i
)
+logf
β,σ
2
(Y
2i
|X
i
,Z
i
)
}
+
∑
j∈
̄
V
log
{
∫
x
f
γ
(T
j
,
j
|x, Y
2j
,Z
j
)
×f
β,σ
2
(Y
2j
|x,Z
j
)dG
X|W
(x|W
j
)
}
.(5)
The parameters contained in the above equation involve
(β,γ,σ
2
), though our main focus is on the inference ofβ
whileγ,σ
2
are nuisance parameters. Later, we will show that
our proposed estimated likelihood estimator is more efficient
than IPW type estimators because we took a joint likelihood
approach and incorporated the failure outcome information
(T, ) in the full cohort. Note that the conditional distribution
ofXgivenW,G
X|W
is involved in (4) and (5).
Thus, we propose to work with the following estimated
likelihood:
ˆ
l
N
(ξ,
0
(t))=
∑
i∈V
{
logf
γ
(T
i
,
i
|X
i
,Y
2i
,Z
i
)
+logf
β,σ
2
(Y
2i
|X
i
,Z
i
)
}
+
∑
j∈
̄
V
log
{
∫
x
f
γ
(T
j
,
j
|x, Y
2j
,Z
j
)
×f
β,σ
2
(Y
2j
|x,Z
j
)d
ˆ
G
X|W
(x|W
j
)
}
,(6)
where we non-parametrically estimate the conditional distri-
butionG
X|W
. For discreteW, let
ˆ
G
X|W
(x|w)=
∑
i∈V
0
I(X
i
≤x,W
i
=w)
/
∑
i∈V
0
I(W
i
=w).
For continuousW, we use the kernel method to estimate
G
X|W
.
ˆ
G
X|W
(x|w)=
∑
i∈V
0
I(X
i
≤x)K
H
(W
i
−w)
/
∑
i∈V
0
K
H
(W
i
−w),
whereK
H
(·)=|H|
−1/2
K(H
−1/2
·) is a multivariate kernel with
a bandwidth matrixH. The optimal bandwidthHcan be
selected using cross-validation, or using an ad hoc value. For
instance, whenWis univariate, a simple bandwidth selec-
tion isH=2
̂σ
W
·n
−1/3
SRS
, wherê
σ
W
is the estimated standard
deviation ofW.
In the estimated likelihood expression (6),f
γ
(T
i
,
i
|
X
i
,Y
2i
,Z
i
) andf
β,σ
2
(Y
2i
|X
i
,Z
i
) can be written in explicit
forms based on linear model (2) and Cox model (3). Under
the assumption that
̃
TandCare conditionally independent,
f
γ
(T
i
,
i
|X
i
,Y
2i
,Z
i
) is equal to
{
λ
0
(T
i
) exp(γ
1
X
i
+γ
2
Y
2i
+γ
3
Z
i
)
}
i
e
−
0
(T
i
) exp(γ
1
X
i
+γ
2
Y
2i
+γ
3
Z
i
)
λ
1−
i
C
(T
i
|X
i
,Y
2i
,Z
i
)e
−
C
(T
i
|X
i
,Y
2i
,Z
i
)
,
whereλ
C
(T|X, Y
2
,Z) is the hazard function ofCgiven
(X, Y
2
,Z), and
C
is the cumulative hazard. Assuming that
Cis independent ofX, logf
γ
(T
i
,
i
|X
i
,Y
2i
,Z
i
) is the sum of
i
logλ
0
(T
i
)+
i
(γ
1
X
i
+γ
2
Y
2i
+γ
3
Z
i
)−
0
(T
i
) exp(γ
1
X
i
+γ
2
Y
2i
+γ
3
Z
i
)
and (1−
i
) logλ
C
(T
i
|Y
2i
,Z
i
)−
C
(T
i
|Y
2i
,Z
i
). The latter term
does not involvexor (ξ,
0
(t)), and thus irrelevant to estimat-
ing the parameters of interest. Also,
logf
β,σ
2
(Y
2i
|X
i
,Z
i
)=−
1
2
log(2
πσ
2
)−
1
2σ
2
(Y
2i
−β
0
−β
1
X
i
−β
2
Z
i
)
2
.
The estimated log-likelihood
ˆ
l
N
(ξ,
0
(t)) has a semi-
parametric form, withξbeing the parametric part and
0
(t)
the non-parametric component. Because the baseline cumu-
lative hazard
0
(t) is unknown, we cannot directly maximize
ˆ
l
N
(ξ,
0
(t)) with respect toξ. We propose to use an inverse
probability weighted partial likelihood estimates from Chen
and Lo (1999) to obtain (
ˆ
γ
0
1
,
ˆ
γ
0
2
,
ˆ
γ
0
3
) as initial parameter esti-
mates for the Cox model (3). We then estimate the baseline
cumulative hazard using a weighted Breslow estimator,
ˆ
0
(t)=
∑
j∈V
I(T
j
≤t)
j
∑
l∈V
ˆ
π
−1
l
I(T
l
≥T
j
) exp(
ˆ
γ
0
1
X
l
+
ˆ
γ
0
2
Y
2l
+
ˆ
γ
0
3
Z
l
)
,
where
ˆ
π
l
=1 for cases, and
ˆ
π
l
=n
SRS
/Nfor non-cases. Fur-
thermore, we use the inverse probability weighted linear
regression on the validation sample to obtain (
ˆ
β
0
0
,
ˆ
β
0
1
,
ˆ
β
0
2
,
ˆ
σ
0
)
as initial parameter estimates for the linear regression model
(2), where cases receive unit weight, and non-cases have
weightN/n
SRS
.
Finally, we plug in the baseline cumulative hazard estimate
ˆ
0
(t) into the estimated log-likelihood, and maximize it with
respect toξ. Let
̃
l
N
(ξ)=
ˆ
l
N
(ξ,
ˆ
0
(t)),
then our proposed non-parametric estimated likelihood esti-
mator
ˆ
ξ
NPEL
is the solution to the following estimating
equation (7):
1
N
∂
̃
l
N
(ξ)
∂ξ
=0.(7)
Newton–Raphson algorithm can now be invoked, where
(
ˆ
γ
0
1
,
ˆ
γ
0
2
,
ˆ
γ
0
3
,
ˆ
β
0
0
,
ˆ
β
0
1
,
ˆ
β
0
2
,
ˆ
σ
0
) are the starting values.
Next, we present the asymptotic property of our proposed
estimator. The following results are provided for the case
whenWis discrete. Asymptotic results forWbeing con-
tinuous can be derived similarly. We assume that asN→∞,
n
V
/N→
̄
π>0, andn
SRS
/n
V
→ρ
SRS
>0. Therefore,
̄
πis the
proportion of validation sample in the overall population.ρ
SRS
represents the proportion of simple random sample in the val-
idation sample. In addition, we letE
k
denote the conditional
expectation given=k. That is,E
k
{h(T, , Y
2
,X,Z)}=
E{h(T, , Y
2
,X,Z)|=k}.Letξ
∗
be the true underlying
value ofξ. Under some general regularity conditions (see Web
Appendix), we have the following theorems.
Regression Analysis for Secondary Response Variable in a Case-Cohort Study1017
Theorem1.(i)
ˆ
ξ
NPEL
is a consistent estimator ofξ
∗
and
(ii)
ˆ
ξ
NPEL
has the following asymptotic distributional proper-
ties:
√
N(
ˆ
ξ
NPEL
−ξ
∗
)
D
−→N(0,
NPEL
(ξ
∗
)).
where
NPEL
(ξ
∗
)=I
−1
(ξ
∗
)+ρ
SRS
̄
πI
−1
(ξ
∗
)(ξ
∗
)I
−1
(ξ
∗
),(ξ)=
var
X,W
{
(1−
̄
π)Q
X,W
(ξ,
0
)
}
, and
I(ξ)=−ρ
SRS
̄
πE
{
∂
2
logf(T, , Y
2
|X,Z;ξ)
∂ξ∂ξ
T
}
−(1−
̄
π)E
0
{
∂
2
logf(T, , Y
2
|Z;ξ)
∂ξ∂ξ
T
}
−(1−ρ
SRS
)
̄
πE
1
{
∂
2
logf(T, , Y
2
|X,Z;ξ)
∂ξ∂ξ
T
}
,(8)
Q
X,W
(ξ,
0
)=
∑
w
P(W=w|=0)
I(W=w)
P(W=w)ρ
SRS
̄
π
×E
T, ,Y
2
,Z|=0
{
M
X
(T, , Y
2
,Z,W=w;ξ,
0
)
}
.
(9)
where
M
X
(T, , Y
2
,Z,W;ξ,
0
)=
∂f
(T, , Y
2
|X,Z;
0
)/∂ξ
∫
f(T, , Y
2
|X,Z;
0
)dG
X|W
(X|W)
−
f
(T, , Y
2
|X,Z;
0
)
∫
∂f(T, , Y
2
|X,Z;
0
)/∂ξdG
X|W
(X|W)
|
∫
f(T, , Y
2
|X,Z;
0
)dG
X|W
(X|W)|
2
.
(10)
Replacing the population quantities in Theorem 1 with
the sample quantities, a consistent estimator for asymptotic
covariance matrix
NPEL
(ξ
∗
) is provided by the following
theorem:
Theorem2.A consistent estimator for variance matrix
NPEL
(ξ
∗
)can be obtained as
̂
NPEL
(
ˆ
ξ
NPEL
)=
ˆ
I
−1
(
ˆ
ξ
NPEL
)+
n
SRS
N
×
ˆ
I
−1
(
ˆ
ξ
NPEL
)
̂
(
ˆ
ξ
NPEL
)
ˆ
I
−1
(
ˆ
ξ
NPEL
),(11)
where
ˆ
I(ξ)=−
1
N
∂
2
̃
l
N
(ξ)
∂ξ∂ξ
T
,and
̂
(ξ)=̂var
{X
i
,W
i
:i∈V
0
}
{
N−n
V
N
̂
Q
X
i
,W
i
(ξ)
}
,with
̂
Q
X
i
,W
i
(ξ)=
∑
j∈
̄
V
1
N−n
V
×
N·I(W
i
=W
j
)
∑
i∈V
0
I(W
i
=W
j
)
×
[
∂f(T
j
,
j
,Y
2j
|X
i
,Z
j
;
ˆ
0
)/∂ξ
ˆ
f(T
j
,
j
,Y
2j
|Z
j
;
ˆ
0
)
−
f(T
j
,
j
,Y
2j
|X
i
,Z
j
;
ˆ
0
)∂
ˆ
f(T
j
,
j
,Y
2j
|Z
j
;
ˆ
0
)/∂ξ
{
ˆ
f(T
j
,
j
,Y
2j
|Z
j
;
ˆ
0
)
}
2
]
,
where
ˆ
f(T
j
,
j
,Y
2j
|Z
j
;
ˆ
0
)=
∫
f(T
j
,
j
,Y
2j
|x,Z
j
;
ˆ
0
)d
ˆ
G
X|W
(x|W
j
).
Outline of the proofs of these two theorems are provided in
Web Appendix A.
4. Derivation of Two New IPW Type Estimators
In this section, we derive two inverse probability weight-
ing type estimators for the secondary outcome analysis. One
is the basic weighted estimator and the other one is the
augmented IPW estimator. Though the general ideas of prob-
ability weighted estimator is there (Horvitz and Thompson,
1952), we develop out these ideas explicitly as competing esti-
mators for the proposed
ˆ
ξ
NPEL
. Later in the simulation study,
we will compare our proposed estimator to these two IPW
type estimators.
The first IPW estimator
ˆ
β
IPW
, is a basic weighted least
squares estimator, where the weight is taken as the inverse of
the selection probability into the validation sample. That is,
we want to minimize
∑
i∈V
1
π
i
(Y
2i
−β
0
−β
1
X
i
−β
2
Z
i
)
2
=
N
∑
i=1
R
i
π
i
(Y
2i
−β
0
−β
1
X
i
−β
2
Z
i
)
2
,
whereπ
i
is the selection probability for theith subject. In the
case-cohort design,π
i
=1 for cases, as all cases are included
into the validation sample. For non-cases,π
i
=n
SRS
/N, the
probability of being selected into the SRS portion of the
validation sample. Let
̃
X
i
=(1,X
i
,Z
i
) be the vector of covari-
ates for theith subject, including the intercept. It is easy to
see that the IPW estimator
ˆ
β
IPW
satisfies the following score
equation:
N
∑
i=1
R
i
π
i
̃
X
T
i
(Y
2i
−
̃
X
i
β)=0.(12)
We notice that in (12), all cases will receive unit weights,
and all non-cases selected into the validation sample will have
weights larger than one. The inverse probability weighting
method will give an unbiased estimator of the parametersβ.
However it may also result in reduced efficiency, since the
cases would always receive smaller weights than non-cases
regardless of whether the case status is linked to the secondary
outcome/exposure relationship.
The second IPW estimator,
ˆ
β
AIPW
, is an augmented IPW
that incorporates the available information in the full cohort.
Similar to Robins et al. (1994), we have the following estimat-
ing equation:
N
∑
i=1
[
R
i
π
i
̃
X
T
i
(Y
2i
−
̃
X
i
β)+
(
1−
R
i
π
i
)
E
X
i
|Y
2i
,Z
i
{
̃
X
T
i
(Y
2i
−
̃
X
i
β)
}
]
=0,
(13)
where an augmented term is added. The second term in
(13) involvesE(X
i
|Y
2i
,Z
i
) andE(X
2
i
|Y
2i
,Z
i
). We use a lin-
ear regression to approximate these moments, that is,E(X
i
|
Y
2i
,Z
i
)=φ
0
+φ
1
Y
2i
+φ
2
Z
i
, Var(X
i
|Y
2i
,Z
i
)=τ
2
. Based on
1018Biometrics, September2018
SRS portion of the data, a linear regression can be fitted to
obtain parameter estimates for (φ
0
,φ
1
,φ
2
,τ
2
). After plugging
(
ˆ
φ
0
,
ˆ
φ
1
,
ˆ
φ
2
,
ˆ
τ
2
) into (13), Newton–Raphson algorithm can be
invoked to obtain
ˆ
β
AIPW
.
5. Simulation Studies
We conducted a series of simulation studies. First, we evalu-
ated the performance of our estimator when the underlying
assumption is met. Then, we further broaden out to evaluate
the proposed method under situations where models are mis-
specified: (i) IfW, the informative components ofZabout
X, is misspecified. (ii) The error termin linear model (2)
is not normally distributed. (iii) The proportional hazards
assumption does not hold.
Five competing estimators are compared: (i)
ˆ
β
N
, linear
regression of the secondary responseY
2
on (X,Z) based on
the validation sample (union of subcohort and cases). This
naive estimator ignores the biased sampling nature of the
data, and can be grossly misleading; (ii)
ˆ
β
SRS
, fitting a lin-
ear regression ofY
2
on (X,Z) based on the SRS portion of
the validation sample; (iii)
ˆ
β
IPW
denotes the inverse prob-
ability weighting method using only the observations from
the validation sample; (iv)
ˆ
β
AIPW
denotes the augmented
inverse probability weighting method we derive in Section
4 which incorporates the available information in the full
cohort; (v)
ˆ
β
NPEL
denotes the estimated likelihood method we
proposed.
In the first set of studies, we let the full cohort size
to beN=1000. The data were generated by the follow-
ing models:Y
2
=β
0
+β
1
X+β
2
Z+,whereX∼N(0,1),Z∼
Bernoulli(0.45), and∼N(0,1). We setβ
0
=1,β
2
=−0.5,
and allowβ
1
to take value 0 or 0.5. The event time
̃
T
follows an exponential distribution with hazard function:
λ(t|X, Y
2
,Z)=λ
0
(t) exp(γ
1
X+γ
2
Y
2
+γ
3
Z),withλ
0
(t)=1,
γ
1
=0.5,γ
3
=−0.5, andγ
2
takes value 0 or log(3). We assume
that the censoring time follows a uniform distribution on
interval (0,C). Whenγ
2
=0,C=0.52 or 0.15 corresponds
to 80% or 95% censoring, respectively. Whenγ
2
=log(3),
C=0.16 or 0.02 corresponds to 80% or 95% censoring,
respectively.
From the full cohort, we first select a simple random sample
of sizen
SRS
=200, then we add all cases for the case-cohort
sample. As we are mainly interested in studying the relation-
ship between the secondary outcomeY
2
and the expensive
exposureX, we focus on the estimation ofβ
1
. We assume that
the informative components ofWisZ. SinceZis discrete, we
use the empirical distribution function to estimate the condi-
tional distribution ofXgivenZ. We report the mean of the
parameter estimates, empirical standard deviation, mean of
the estimated standard deviation, and 95% confidence inter-
val coverage. Simulation results based on 1000 replications are
shown in Table 1.
We find that all estimators yield approximately unbiased
estimates except
ˆ
β
N
.
ˆ
β
N
performs well when the secondary
outcome is not correlated with the time-to-event outcome
(γ
2
=0). However, it has bias and poor coverage rate when
γ
2
=0. The bias is even larger when censoring percent
increases (rare event). Similar findings were reported by Lin
and Zeng (2009) in secondary analysis of case-control data.
Table 1
Simulation results with full cohort sizeN=1000, the SRS
sample size isn
SRS
=200.X∼N(0,1),Z∼Bernoulli(0.45).
Estimated quantities forβ
1
Trueβ
1
Trueγ
2
MethodsBiasSD
̂
SDCI
Censoring percentage = 80%
00
ˆ
β
N
0.001 0.050 0.052 0.950
ˆ
β
SRS
0.000 0.070 0.071 0.948
ˆ
β
IPW
0.002 0.063 0.063 0.950
ˆ
β
AIPW
0.002 0.064 0.063 0.944
ˆ
β
NPEL
0.002 0.051 0.052 0.945
log(3)
ˆ
β
N
0.024 0.054 0.054 0.925
ˆ
β
SRS
0.000 0.071 0.071 0.947
ˆ
β
IPW
0.001 0.062 0.061 0.947
ˆ
β
AIPW
0.002 0.063 0.062 0.944
ˆ
β
NPEL
0.001 0.053 0.052 0.945
0.50
ˆ
β
N
−0.003 0.051 0.052 0.959
ˆ
β
SRS
−0.005 0.071 0.071 0.953
ˆ
β
IPW
−0.005 0.063 0.063 0.939
ˆ
β
AIPW
−0.002 0.054 0.055 0.954
ˆ
β
NPEL
−0.005 0.046 0.048 0.955
log(3)
ˆ
β
N
0.025 0.052 0.051 0.922
ˆ
β
SRS
−0.001 0.071 0.071 0.945
ˆ
β
IPW
0.000 0.063 0.060 0.935
ˆ
β
AIPW
0.004 0.056 0.054 0.944
ˆ
β
NPEL
−0.001 0.047 0.047 0.950
Censoring percentage = 95%
0.5log(3)
ˆ
β
N
0.084 0.066 0.065 0.729
ˆ
β
SRS
−0.001 0.073 0.071 0.940
ˆ
β
IPW
0.002 0.069 0.066 0.928
ˆ
β
AIPW
0.005 0.062 0.059 0.933
ˆ
β
NPEL
0.000 0.058 0.058 0.943
Note: The models areY
2
=β
0
+β
1
X+β
2
Z+,λ(t|X, Y
2
,Z)=
λ
0
(t) exp(γ
1
X+γ
2
Y
2
+γ
3
Z).
From Table 1, we draw several other conclusions. (i) The
proposed estimated likelihood estimator
ˆ
β
NPEL
is the most
efficient in all settings. (ii) The estimated standard devia-
tion is very close to the empirical standard deviation (i.e.,
̂
SDis close to SD). (iii) The 95% confidence interval cover-
age is close to 0.95, which implies that the asymptotic normal
approximation works well in these situations. (iv) We also
notice that whenβ
1
is significantly different from 0 (i.e.,
β
1
=0.5),
ˆ
β
AIPW
outperforms
ˆ
β
IPW
by a certain margin. The
difference between these two estimators is negligible when
β
1
=0.
We conducted further simulation studies to assess the per-
formance of our proposed estimator under a wide range of
proportion of SRS sample in the full cohort, and under vari-
ous censoring percentages. Simulation results are provided in
Web Appendix B.
Regression Analysis for Secondary Response Variable in a Case-Cohort Study1019
5.1.Misspecification ofW, the Informative Components
ofZAboutX
To study the performance of
ˆ
β
NPEL
whenWis misspecified,
we generate the data by the following models:Y
2
=β
0
+β
1
X+
β
2
Z
1
+β
3
Z
2
+,whereZ
1
∼Bernoulli(0.45),Z
2
∼Bernoulli
(0.6),∼N(0,1). The expensive exposureXis simulated
as:X∼N(Z
1
,1). LetZ=(Z
1
,Z
2
), thenG(X|Z)=G(X|Z
1
),
that is, the trueWisZ
1
. We setβ
0
=1,β
2
=−0.5,β
3
=
2, and allowβ
1
to take value 0 or 0.5. The event
time
̃
Tfollows an exponential distribution with haz-
ard function:λ(t|X, Y
2
,Z)=λ
0
(t) exp(γ
1
X+γ
2
Y
2
+γ
3
Z
1
+
γ
4
Z
2
),withλ
0
(t)=1,γ
1
=0.5,γ
2
=log(1.2),γ
3
=−0.5 and
γ
4
=1. The censoring time follows a uniform distribution
on interval (0,0.14), which leads to 80% censoring. Same as
before,N=1000 andn
SRS
=200. We consider three scenar-
ios: (i) We estimate the conditional distributionG(X|Z)by
assuming thatWisZ
2
. This is the case whereWis misspec-
ified. (ii) We assume thatWisZ
1
. (iii) We assume thatW
is (Z
1
,Z
2
).
Table 2 summarizes the simulation results. Under null
hypothesis (β
1
=0),
ˆ
β
NPEL
has good performance even if we
misspecifyW. However, whenβ
1
is significantly different from
0 (i.e.,β
1
=0.5), misspecification ofW(usingZ
2
only) would
lead to substantial bias and poor coverage probability of 95%
CI. In the Discussion Section, we will provide practical guid-
ance on how to chooseW. The general idea is that we should
select the components ofZthat correlates toXthe most.
5.2.Parametric versus Non-Parametric Estimation ofX
GivenZ
We compare our proposed estimator
ˆ
β
NPEL
to a parametric
maximum likelihood estimator
ˆ
β
PL
, where we parametrically
specifyG
X|Z
(i.e., conditional normal) to a set of additional
parametersλ, and then directly maximize the log-likelihood
function in (5) with respect toξandλ. The simulation set up
is the same as Table 2, except forX. We consider the follow-
ing three scenarios: (i)X∼N(0,1). (ii)Xfollows a gamma
distribution with shape parameter 0.5 and rate parameter 1.
(iii)Xfollows an exponential distribution with rate parameter
0.5.
Table 2
Performance of our proposed estimator
ˆ
β
NPEL
when we
misspecifyW.Z=(Z
1
,Z
2
), whereZ
1
∼Bernoulli(0.45),
Z
2
∼Bernoulli(0.6).X∼N(Z
1
,1), which means thatZ
1
is
the informative components ofZaboutX. The trueWisZ
1
.
Estimated quantities forβ
1
Trueβ
1
WusedBiasSD
̂
SDCI
0Z
1
0.0010.0530.0520.952
Z
2
0.0010.0490.0490.936
(Z
1
,Z
2
)0.0010.0530.0520.954
0.5Z
1
−0.0020.0460.0470.958
Z
2
−0.0630.0440.0450.728
(Z
1
,Z
2
)−0.0070.0460.0480.964
Note: Models areY
2
=β
0
+β
1
X+β
2
Z
1
+β
3
Z
2
+,λ(t|X, Y
2
,Z)=
λ
0
(t) exp(γ
1
X+γ
2
Y
2
+γ
3
Z
1
+γ
4
Z
2
).
Table 3 displays the results.
ˆ
β
PL
has large bias and can be
grossly misleading whenG
X|Z
is misspecified. On the other
hand, our proposed estimator
ˆ
β
NPEL
works well in all settings.
Another disadvantage of parametric MLE is that it requires
numerical integration overX, and is hence computationally
intensive.
5.3.Misspecification of the Error Distribution for the
Secondary Outcome or Misspecification of the
Survival Model
We conducted additional simulations to examine the perfor-
mance of our estimator for the secondary outcome parameters
when the error distribution for the secondary outcome model
is misspecified or when the survival model is misspecified.
The simulation set up is the same as Table 2, except for the
error term and the model for time to event outcome. We con-
sider five scenarios: (i) the error term is a gamma distribution
with shape parameter 2, rate parameter 1, then normalized to
have mean 0 and variance 1. This error term is right-skewed.
(ii) The error term depends onZ
1
, which is a standard nor-
mal distribution multiplied by (1+Z
2
1
)
3/4
/2. (iii) The error
term depends onX, which is a standard normal distribution
multiplied by (1+X
2
)
3/4
/2. (iv) The event time
̃
Tcomes
from an Accelerated Failure Time (AFT) model: log
̃
T=
0.5X+Y
2
−0.5Z
1
+Z
2
+e, wheree∼N(0,1). (v) The event
time follows an Additive Hazards model:λ(t)=10+0.5X+
Y
2
−0.5Z
1
+Z
2
.
Simulation results are summarized in Table 4, where we use
Z
1
to estimateG(X|Z). We have the following conclusions:
(a) when the error term is skewed (not symmetric around 0),
ˆ
β
IPW
and
ˆ
β
AIPW
performs relatively well, while
ˆ
β
NPEL
has larger
bias. This comes from the fact that the estimated likelihood
estimator is more reliant on the normality assumption. On the
other hand, the IPW and AIPW estimator we developed do
not explicitly use the normality assumption of the error term.
(b) When the error term is heteroscedastic, but not depend
Table 3
Parametric versus non-parametric estimation ofXgivenZ
Estimated quantities forβ
1
MethodsBiasSD
̂
SDCI
Xis normal
ˆ
β
PL
0.0050.0490.0640.926
ˆ
β
NPEL
−0.0050.0500.0500.957
Xfollows a gamma
distribution
ˆ
β
PL
−0.0230.0550.0960.913
ˆ
β
NPEL
−0.0050.0590.0600.962
Xfollows an exponential
distribution
ˆ
β
PL
−0.0510.0170.0150.143
ˆ
β
NPEL
−0.0010.0170.0170.956
Note: Models areY
2
=β
0
+β
1
X+β
2
Z
1
+β
3
Z
2
+.λ(t|X, Y
2
,Z)=
λ
0
(t) exp(γ
1
X+γ
2
Y
2
+γ
3
Z
1
+γ
4
Z
2
).
ˆ
β
NPEL
,proposednon-
parametric estimated likelihood estimator.
ˆ
β
PL
, parametric
maximum likelihood estimator assuming thatXgivenZis normal.
1020Biometrics, September2018
Table 4
Simulation results when the error termis misspecified or the survival model is misspecified.Z=(Z
1
,Z
2
), where
Z
1
∼Bernoulli(0.45),Z
2
∼Bernoulli(0.6),X∼N(Z
1
,1).β
1
=0.5.
Estimated quantities forβ
1
MethodsBiasSD
̂
SDCI
Misspecification of
(i) Gamma error misspecified asN(0,σ
2
)
ˆ
β
IPW
−0.0010.0630.0610.936
ˆ
β
AIPW
0.0070.0650.0610.916
ˆ
β
NPEL
−0.0330.0510.0490.889
(ii) Heteroscedastic error (related toZ
1
) misspecified asN(0,σ
2
)
ˆ
β
IPW
0.0010.0440.0420.937
ˆ
β
AIPW
0.0040.0370.0360.942
ˆ
β
NPEL
−0.0040.0320.0320.956
(iii) Heteroscedastic error (related toX) misspecified asN(0,σ
2
)
ˆ
β
IPW
0.0010.0990.0960.940
ˆ
β
AIPW
0.0030.0960.0930.928
ˆ
β
NPEL
−0.0130.0740.0510.818
Misspecification of survival model
(iv) AFT misspecified as PH
ˆ
β
IPW
0.0050.0640.0630.940
ˆ
β
AIPW
0.0070.0570.0560.930
ˆ
β
NPEL
−0.0050.0490.0490.951
(v) Additive Hazards misspecified as PH
ˆ
β
IPW
0.0020.0670.0640.937
ˆ
β
AIPW
0.0080.0600.0560.912
ˆ
β
NPEL
0.0010.0490.0490.948
Note: Models for secondary outcome isY
2
=β
0
+β
1
X+β
2
Z
1
+β
3
Z
2
+. AFT, Accelerated Failure Time; PH, Proportional Hazards.
onX, the proposed
ˆ
β
NPEL
is unbiased and the most efficient
among all estimators. (c) When the error term depends onX,
ˆ
β
NPEL
is still unbiased, but the asymptotic covariance estima-
tor tends to underestimate the empirical covariance. (d) Even
though the true model for
̃
Tis AFT or Additive Hazards and
we fit Cox model, our proposed estimator
ˆ
β
NPEL
still works
very well in terms of estimating the parameters in model (2).
In practice, we could first fit a linear regression ofY
2
on
(X,Z) based on SRS portion of the data to check the normal-
ity and homogeneity assumption. If we find that the residual
depends onX, we need to employ some variable transforma-
tion techniques to obtain a more homogeneous error term.
After that, our estimated likelihood method can be used.
6. Analysis of Sister Study Data
We applied our method to data from the Sister Study (Kim
et al., 2011, 2013) to assess the relationship between BMI
and PGE-M. The Sister Study is a cohort study conducted
on U.S. women aged 35–74. To be eligible, women cannot have
breast cancer themselves at the start of the study but have
a sister with breast cancer. The participants come from all
50 states and Puerto Rico, and were recruited by health pro-
fessionals, internet, and a national campaign. The enrollment
time is from 2003 to 2009. Twenty-five thousand and eight
hundred subjects completed the baseline activities by June 1,
2007. We further restrict the study population to women who
are postmenopausal, age 50 or older, and not currently using
hormone replacement therapies, which yields a full cohort of
size 11,338.
Information on subject’s breast cancer status is followed-up
via annual and biennial questionnaires until September 2010.
Other information such as age, BMI, medication use are col-
lected for each member in the full cohort (N=11,338). In the
original study, the primary interest is to assess the effect of
PGE-M on the risk of breast cancer. Because the measure-
ment of PGE-M level from urine samples can be expensive,
a case-cohort design is implemented. A simple random sam-
ple of 300 participants were selected from the eligible full
cohort. Then 307 supplemental cases were added to create
a case-cohort sample. PGE-M levels were quantified for the
subcohort members and the supplemental cases.
Prior research indicate that obesity might be posi-
tively related to prostaglandin E2 (Morris et al., 2011;
Subbaramaiah et al., 2011). In this analysis, we use normal-
ized BMI as the secondary outcome and normalized PGE-M
as the exposure which is only available on the case-cohort
sample. Additional confounding variables include use of
Regression Analysis for Secondary Response Variable in a Case-Cohort Study1021
nonsteroidal anti-inflammatory drugs (NSAIDS), current
drinking status, current smoking status, indicator variables of
older than 60 and waist circumference larger than 35 inches.
We fit the following two models:
BMI=β
0
+β
1
PGEM+β
2
NSAIDS+β
3
DRINKING
+β
4
AGE+,
λ(t)=λ
0
(t) exp(γ
1
PGEM+γ
2
BMI+γ
3
NSAIDS+γ
4
AGE
+γ
5
WAIST+γ
6
SMOKE),
whereλ(t) is the conditional hazard of breast cancer given
PGE-M, BMI and other covariates. The estimated conditional
distribution of the expensive exposure PGE-M given other
covariates is based on use of NSAIDS, current drinking status,
and an indicator variable of older than 60.
The results are shown in Table 5. All three analyses confirm
that PGE-M level is significantly related to BMI. The pro-
posed estimator in general provides a more precise estimate
of the effects. Most of the variance estimates for the proposed
method are smaller than those from competing methods. All
three analyses confirm that there is a positive relationship
between BMI and use of NSAIDS, and that there is a negative
relationship between current drinking, age, and BMI.
7. Discussion
To study the hard-to-obtain exposure variable that is only
measured in a case-cohort study with some other important
responses is desired by all investigators. However, how to
properly account for the biased sampling nature of a case-
cohort study in a secondary outcome regression analysis, or
how to best utilize the available data to achieve a more effi-
cient inference is not a well thought out issue. Without loss
of generality, we assume a linear model for the secondary
response and our goal in this article is to obtain unbiased and
efficient estimates for the linear model parameters in model
(2). We propose a new and efficient estimator for the sec-
ondary outcome regression analysis in a case-cohort study.
Our estimation is based on jointly modeling the time-to-event
outcome and the secondary response. The joint likelihood
is not tractable as the conditional distribution of expensive
exposure given other inexpensive covariates as well as the
baseline cumulative hazard are not specified. We estimate this
conditional distribution and the baseline cumulative hazard
function non-parametrically. Our proposed method has the
advantage of making no new parametric assumptions, and
yet still able to improve efficiency relative to other competing
estimators.
In the simulation studies, we find that misspecification of
Wwould lead to certain degree of bias. We suggest the follow-
ing practical guidelines on how to chooseW. Due to “curse of
dimensionality,” theWwe use should not be more than three
components in general, unless the SRS sample size is very
large. When covariatesZhas low dimension (i.e.,≤3), one
can simply include all covariates intoW. When the dimen-
sion ofZis medium (i.e., 3< dim(Z)<10), we suggest to
calculate the correlation betweenXand each covariate in
Z, and then select three most correlated components. When
the dimension ofZis high (i.e.,≥10), we suggest to use
dimension-reduction techniques such as principal component
analysis to get a lower dimensional
̃
Z, then our proposed esti-
mated likelihood method can be carried out by using
̃
Zas the
regression covariates and the informative componentsW.
Our proposed estimated likelihood method requires spec-
ifying a model for the time-to-event outcome. However, in
the simulation studies, we found that our proposed estimator
works very well in estimating the parameters in the secondary
outcome model, even if we completely misspecified the model
for the time-to-event outcome. In the future, it is interest-
ing to see if we can altogether avoid specifying a model for
the time-to-event outcome, and still make valid and efficient
inference on the secondary response.
Even though we present our method in the setting where
the subcohort is selected as a simple random sample from
the full cohort, our method also works when the subcohort
sampling probabilities depend onZ(e.g., stratified random
sampling with respect toZ). This is because our method only
involves estimating the conditional distributionG
X|Z
. When
the subcohort sampling depends on the survival outcome, our
method cannot be directly applied and needs modification.
This is another area of our future research.
Table 5
Analysis of Sister Study
Proposed ELSRSIPW
Estimate
̂
SDEstimate
̂
SDEstimate
̂
SD
Linear ModelInt0.0200.0610.3940.1580.3370.135
(outcome: BMI)PGE-M0.3610.0520.1940.0570.1860.049
NSAIDS0.3970.0490.2570.1160.3080.100
DRINKING−0.2660.055−0.4340.140−0.4460.120
AGE−0.1110.046−0.2660.115−0.2130.099
Cox ModelPGE-M0.1850.103−0.1830.4480.1900.250
BMI0.0810.1250.2690.4260
.1540.397
NSAIDS0.2490.175−0.4930.7190.5800.666
AGE0.0390.183−0.2270.797−0.1930.601
WAIST0.0370.243−0.0610.979−0.2310.860
SMOKE0.4690.331−17.177040.4491.031
1022Biometrics, September2018
Our approach can be extended in several other ways.
Although we use a linear model (2) for the association between
the secondary responseY
2
and all covariates (X,Z), our
method can be applied to other discrete or continuous sec-
ondary outcomes, as long as the conditional distribution of
Y
2
given (X,Z) is specified parametrically. Our models can
also be easily generalized to the case in which the linear
model (2) and Cox model (3) have different covariates. In
our article, we use the empirical distribution to estimate the
conditional distributionG
X|W
whenWis discrete, and use
the kernel method whenWis continuous. WhenWhas both
discrete and continuous components, the product kernel esti-
mator from Li and Racine (2008) could be used. In addition,
instead of assuming that the error termin the linear model
(2) follows a normal distribution, we are working on a more
robust semiparametric estimation where the only assumption
we make isE(|X,Z)=0.
8. Supplementary Materials
Web Appendices referenced in Section 3 and 5, along with the
sourceRcodes for implementing the proposed methods, are
available with this article at theBiometricswebsite on Wiley
Online Library.
Acknowledgements
The authors thank the editors and referees for very construc-
tive comments that greatly improved the presentation of this
article. This research is part of Yinghao Pan’s Ph.D. disserta-
tion. It is partially supported by grants R01 ES021900 from
the National Institute of Environmental Health Sciences and
P01 CA142538 from the National Cancer Institute.
References
Borgan, O., Langholz, B., Samuelsen, S. O., Goldstein, L., and
Pogoda, J. (2000). Exposure stratified case-cohort designs.
Lifetime Data Analysis6,39
–58.
Chen, K. and Lo, S.-H. (1999). Case-cohort and case-control anal-
ysis with cox’s model.Biometrika86, 755
–764.
Cox, D. R. (1972). Regression models and life tables (with discus-
sion).Journal of the Royal Statistical Society34, 187
–220.
Horvitz, D. G. and Thompson, D. J. (1952). A generalization of
sampling without replacement from a finite universe.Journal
of the American Statistical Association47, 663
–685.
Jiang, Y., Scott, A. J., and Wild, C. J. (2006). Secondary analysis
of case-control data.Statistics in Medicine25, 1323
–1339.
Kang, S. and Cai, J. (2009). Marginal hazards model for case-
cohort studies with multiple disease outcomes.Biometrika
96, 887
–901.
Kim, S., Cai, J., and Lu, W. (2013). More efficient estimators for
case-cohort studies.Biometrika100, 695
–708.
Kim, S., Sandler, D. P., Carswell, G., De Roo, L. A., Parks, C. G.,
Cawthon, R., et al. (2011). Telomere length in peripheral
blood and breast cancer risk in a prospective case-cohort
analysis: results from the sister study.Cancer Causes &
Control22, 1061
–1066.
Kim, S., Taylor, J. A., Milne, G. L., and Sandler, D. P. (2013).
Association between urinary prostaglandin e2 metabolite
and breast cancer risk: A prospective, case–cohort study
of postmenopausal women.Cancer Prevention Research6,
511
–518.
Kulich, M. and Lin, D. (2004). Improving the efficiency of
relative-risk estimation in case-cohort studies.Journal of
the American Statistical Association99, 832
–844.
Lee, A., McMurchy, L., and Scott, A. (1997). Re-using data from
case-control studies.Statistics in Medicine16, 1377
–1389.
Li, Q. and Racine, J. S. (2008). Nonparametric estimation of
conditional cdf and quantile functions with mixed categor-
ical and continuous data.Journal of Business & Economic
Statistics26, 423
–434.
Lin, D. and Zeng, D. (2009). Proper analysis of secondary phe-
notype data in case-control association studies.Genetic
Epidemiology33, 256
–265.
Ma, Y. and Carroll, R. J. (2016). Semiparametric estimation in the
secondary analysis of case–control studies.Journal of the
Royal Statistical Society, Series B (Statistical Methodology)
78, 127
–151.
Monsees, G. M., Tamimi, R. M., and Kraft, P. (2009). Genome-
wide association scans for secondary traits using case-control
samples.Genetic Epidemiology33, 717
–728.
Morris, P. G., Hudis, C. A., Giri, D., Morrow, M., Falcone, D.
J., Zhou, X. K., et al. (2011). Inflammation and increased
aromatase expression occur in the breast tissue of obese
women with breast cancer.Cancer Prevention Research4,
1021
–1029.
Prentice, R. L. (1986). A case-cohort design for epidemiologic
cohort studies and disease prevention trials.Biometrika73,
1
–11.
Richardson, D. B., Rzehak, P., Klenk, J., and Weiland, S.
K. (2007). Analyses of case–control data for additional
outcomes.Epidemiology18, 441
–445.
Robins, J. M., Rotnitzky, A., and Zhao, L. P. (1994). Estimation of
regression coefficients when some regressors are not always
observed.Journal of the American Statistical Association
89, 846
–866.
Saarela, O., Kulathinal, S., Arjas, E., and L ̈a ̈ar ̈a, E. (2008).
Nested case–control data utilized for multiple outcomes: A
likelihood approach and alternatives.Statistics in Medicine
27, 5991
–6008.
Saarela, O., Kulathinal, S., and Karvanen, J. (2012). Secondary
analysis under cohort sampling designs using conditional
likelihood.Journal of Probability and Statistics2012,
Article ID 931416.
Salim, A., Xiangmei, M., Jialiang, L., and Reilly, M. (2014). A
maximum likelihood method for secondary analysis of nested
case-control data.Statistics in Medicine33, 1842
–1852.
Self, S. G. and Prentice, R. L. (1988). Asymptotic distribution
theory and efficiency results for case-cohort studies.The
Annals of Statistics16,64
–81.
Subbaramaiah, K., Howe, L. R., Bhardwaj, P., Du, B., Gravaghi,
C., Yantiss, R. K., et al. (2011). Obesity is associated with
inflammation and elevated aromatase expression in the
mouse mammary gland.Cancer Prevention Research4,
329
–346.
Wang, X. and Zhou, H. (2006). A semiparametric empirical like-
lihood method for biased sampling schemes with auxiliary
covariates.Biometrics62, 1149
–1160.
Wang, X. and Zhou, H. (2010). Design and inference for cancer
biomarker study with an outcome and auxiliary-dependent
subsampling.Biometrics66, 502
–511.
Wei, J., Carroll, R. J., M ̈uller, U. U., Keilegom, I. V., and
Chatterjee, N. (2013). Robust estimation for homoscedastic
regression in the secondary analysis of case–control data.
Journal of the Royal Statistical Society, Series B (Statistical
Methodology)75, 185
–206.
Received January2017. Revised November2017.
Accepted November2017.